| Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment MAA Binnewijzend, MM Schoonheim, E Sanz-Arigita, AM Wink, ... Neurobiology of aging 33 (9), 2018-2028, 2012 | 470 | 2012 |
| Blood–brain barrier P-glycoprotein function in Alzheimer's disease DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ... Brain 135 (1), 181-189, 2012 | 358 | 2012 |
| Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding N Tolboom, WM van der Flier, M Yaqub, R Boellaard, NA Verwey, ... Journal of Nuclear Medicine 50 (9), 1464-1470, 2009 | 215 | 2009 |
| Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET R Ossenkoppele, N Tolboom, JC Foster-Dingley, SF Adriaanse, ... European journal of nuclear medicine and molecular imaging 39, 990-1000, 2012 | 193 | 2012 |
| Longitudinal amyloid imaging using 11C-PiB: methodologic considerations BNM van Berckel, R Ossenkoppele, N Tolboom, M Yaqub, ... Journal of Nuclear Medicine 54 (9), 1570-1576, 2013 | 182 | 2013 |
| Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET N Tolboom, M Yaqub, WM Van Der Flier, R Boellaard, G Luurtsema, ... Journal of Nuclear Medicine 50 (2), 191-197, 2009 | 174 | 2009 |
| Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement R Ossenkoppele, MD Zwan, N Tolboom, DME van Assema, SF Adriaanse, ... Brain 135 (7), 2115-2125, 2012 | 144 | 2012 |
| Simplified parametric methods for [11C] PIB studies M Yaqub, N Tolboom, R Boellaard, BNM van Berckel, EW van Tilburg, ... Neuroimage 42 (1), 76-86, 2008 | 109 | 2008 |
| Family‐based genetic association study of DLGAP3 in Tourette Syndrome J Crane, J Fagerness, L Osiecki, B Gunnell, SE Stewart, DL Pauls, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 …, 2011 | 88 | 2011 |
| Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease N Tolboom, M Yaqub, R Boellaard, G Luurtsema, AD Windhorst, ... European journal of nuclear medicine and molecular imaging 36, 1629-1638, 2009 | 83 | 2009 |
| Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C] PIB and [18F] FDDNP PET images N Tolboom, WM van Der Flier, J Boverhoff, M Yaqub, MP Wattjes, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (8), 882-884, 2010 | 75 | 2010 |
| Image-derived input functions for PET brain studies JEM Mourik, M Lubberink, A Schuitemaker, N Tolboom, BNM van Berckel, ... European journal of nuclear medicine and molecular imaging 36, 463-471, 2009 | 74 | 2009 |
| Amyloid and its association with default network integrity in Alzheimer's disease SM Adriaanse, EJ Sanz‐Arigita, MAA Binnewijzend, R Ossenkoppele, ... Human brain mapping 35 (3), 779-791, 2014 | 60 | 2014 |
| Nuclear medicine imaging in neuroblastoma: current status and new developments A Samim, GAM Tytgat, G Bleeker, STM Wenker, KLS Chatalic, AJ Poot, ... Journal of Personalized Medicine 11 (4), 270, 2021 | 55 | 2021 |
| Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment N Tolboom, WM van der Flier, M Yaqub, T Koene, R Boellaard, ... Neurology 73 (24), 2079-2085, 2009 | 55 | 2009 |
| PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group NL Albert, N Galldiks, BM Ellingson, MJ van den Bent, SM Chang, ... The Lancet Oncology 25 (1), e29-e41, 2024 | 54 | 2024 |
| Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET D Fällmar, S Haller, J Lilja, T Danfors, L Kilander, N Tolboom, K Egger, ... European radiology 27, 4237-4246, 2017 | 46 | 2017 |
| Peripheral metabolism of [18F] FDDNP and cerebral uptake of its labelled metabolites G Luurtsema, RC Schuit, K Takkenkamp, M Lubberink, NH Hendrikse, ... Nuclear medicine and biology 35 (8), 869-874, 2008 | 41 | 2008 |
| Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings N Tolboom, ELGE Koedam, JM Schott, M Yaqub, MA Blankenstein, ... Alzheimer Disease & Associated Disorders 24 (3), 303-307, 2010 | 36 | 2010 |
| FDA approval of lecanemab: the real start of widespread amyloid PET use?—the EANM Neuroimaging Committee perspective A Verger, I Yakushev, NL Albert, B van Berckel, M Brendel, D Cecchin, ... European journal of nuclear medicine and molecular imaging 50 (6), 1553-1555, 2023 | 35 | 2023 |
Philip ScheltensProfessor of NeurologyEmail yang diverifikasi di amsterdamumc.nl
